NCT06216938 2026-04-13RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node MetastasisUniversity of PittsburghPhase EARLY_PHASE1 Recruiting25 enrolled
NCT05704933 2026-04-06Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain MetastasesH. Lee Moffitt Cancer Center and Research InstitutePhase EARLY_PHASE1 Completed1 enrolled